Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen-Reference-Cited by-同舟云学术

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

Published:2005-04-04 Issue:10 Volume:35 Page:943-951
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Anderlini P,Saliba R,Acholonu S,Okoroji G-J,Donato M,Giralt S,Andersson B,Ueno N T,Khouri I,De Lima M,Hosing C,Cohen A,Ippoliti C,Romaguera J,Rodriguez M A,Pro B,Fayad L,Goy A,Younes A,Champlin R E

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704942.pdf

Reference23 articles.

1. Urba WJ, Longo DL . Hodgkin's disease. N Engl J Med 1992; 326: 678–687.

2. Aisenberg AC . Problems in Hodgkin's disease management. Blood 1999; 93: 761–779.

3. Linch DC, Goldstone AH . High-dose therapy for Hodgkin's disease. Br J Haematol 1999; 107: 685–690.

4. Forman SJ . Role of High-Dose Therapy and Stem Cell Transplantation in the Management of Hodgkin's Disease. American Society of Clinical Oncology (ASCO) Educational Book: Alexandria, VA, 1997, pp 244–247.

5. Johnston LJ, Horning SJ . Autologous hematopoietic cell transplantation in Hodgkin's disease. Biol Blood Marrow Transplant 2000; 6: 289–300.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents;Cancer Medicine;2023-01-18

2. Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma;Transplantology;2021-10-03

3. Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies;Therapeutic Advances in Hematology;2020-01

4. Allogeneic Transplantation for Relapsed Hodgkin Lymphoma;Hodgkin Lymphoma;2020

5. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation;Clinical Lymphoma Myeloma and Leukemia;2019-06